{
    "Trade/Device Name(s)": [
        "Emit\u00ae 2000 Cyclosporine Specific Assay"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K053061",
    "Predicate Device Reference 510(k) Number(s)": [
        "P890025"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MKW"
    ],
    "Summary Letter Date": "February 6, 2006",
    "Summary Letter Received Date": "January 13, 2006",
    "Submission Date": "January 6, 2006",
    "Regulation Number(s)": [
        "21CFR862.1235"
    ],
    "Regulation Name(s)": [
        "Cyclosporine test system"
    ],
    "Analyte Class(es)": [
        "transplant",
        "tdm"
    ],
    "Analyte(s)": [
        "Cyclosporine"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Emit\u00ae 2000 Cyclosporine Specific Assay for in vitro quantitative analysis of cyclosporine in whole blood for transplant therapy management.",
    "Indications for Use Summary": "For in vitro quantitative analysis of cyclosporine in human whole blood as an aid in management of cyclosporine therapy in kidney, heart, and liver transplant patients.",
    "fda_folder": "Clinical Chemistry"
}